The pathobiological role of p53 has been widely studied, however, its role in normophysiology is relatively unexplored. We previously showed that p53 knock-down increased ploidy in megakaryocytic cultures. This study aims to examine the effect of p53 loss on in vivo megakaryopoiesis, platelet production, and function, and to investigate the basis for greater ploidy in p53 L/L megakaryocytic cultures. Here, we used flow cytometry to analyze ploidy, DNA synthesis, and apoptosis in murine cultured and bone marrow megakaryocytes following thrombopoietin administration and to analyze fibrinogen binding to platelets in vitro. Culture of p53 L/L marrow cells for 6 days with thrombopoietin gave rise to 1.7-fold more megakaryocytes, 26.1% ± 3.6% of which reached ploidy classes $64 N compared to 8.2% ± 0.9% of p53 +/+ megakaryocytes. This was due to 30% greater DNA synthesis in p53 L/L megakaryocytes and 31% greater apoptosis in p53 +/+ megakaryocytes by day 4 of culture. Although the bone marrow and spleen steady-state megakaryocytic content and ploidy were similar in p53 +/+ and p53 L/L mice, thrombopoietin administration resulted in increased megakaryocytic polyploidization in p53 L/L mice. Although their platelet counts were normal, p53
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Activation of the p53 tumor suppressor generally results in cell cycle arrest and/or induction of apoptosis [1] . Mounting evidence has implicated p53 as a critical regulator of hematopoietic stem cell proliferation, stress hematopoiesis following lethal irradiation, and hematopoietic stem cell aging [2] [3] [4] (reviewed in [5] ). Our recent studies [6] [7] [8] [9] [10] and earlier work by others [11] [12] [13] provided evidence that the p53 pathway, largely unexplored in megakaryopoiesis, plays an important role in megakaryocytic (Mk) differentiation. We have recently shown that knock-down of p53 increased ploidy in Mk cultures [7] . There are relatively few studies that specifically examine megakaryopoiesis or platelet production in the absence of p53. One such study indicated faster recovery of colony-forming unit Mk progenitors (CFU-Mk) after 5-fluorouracil treatment in p53 À/À vs p53 þ/þ mice and a threefold increased bone marrow (BM) content of Lin À Sca-1 þ c-Kit þ cells in p53 À/À mice following 5-fluorouracil treatment [14] . Platelet recovery after irradiation of p53 À/À mice was three times faster [15] , suggesting that p53 loss can result in faster platelet production. Despite the known propensity of p53 À/À mice to succumb to cancer, mainly lymphoma and sarcoma [16] , p53 loss has not been linked to abnormal megakaryopoiesis. On the contrary, a recent study demonstrated that intercrossing of p53 À/À mice with mice engineered to contain an equivalent to the human deletion of the q arm of chromosome 5 (5q-syndrome) and whose BM cells express high levels of the p53 protein, reversed the low Mk/erythroid progenitor levels and low platelet levels encountered in the 5q-syndrome [17] . This study suggests that p53 loss can favor megakaryopoiesis and platelet production. Additionally, a study examining platelet recovery following myelosuppression in p53 À/À and p53 þ/þ mice hypothesized that loss of p53 confers to hematopoietic stem cells and committed Mk precursors the ability to resist apoptosis to the same extent that administration of thrombopoietin (Tpo) supports survival [18] . However, none of these studies examined Mk differentiation in response to Tpo administration in the absence of p53, or Mk/platelet recovery in response to induced thrombocytopenia.
The first aim of this study was to characterize Mk polyploidization in the BM of p53 þ/þ and p53 À/À mice at steady state together with de novo platelet production. Additionally, we aimed to examine the regulation of Mk polyploidization and platelet production in response to (1) treatment of mice with Tpo to promote Mk differentiation and increased thrombopoiesis; and (2) administration of an antiplatelet antibody to specifically target the platelets and elicit an Mk differentiation and platelet production cascade to replenish normal platelet levels in p53 þ/þ and p53 À/À mice. The next question we aimed to address was the impact of p53 on platelet functional responses. The presence of the p53 protein and the p53 inhibitor MDM2 in platelets has been previously documented [19] . However, the effect of the loss or functional inactivation of p53 on hemostasis is unknown. Here, we present findings postulating a reduced hemostatic response in p53 À/À mice. Our study suggests a novel role for p53 in regulating hemostasis, perhaps by affecting components of the platelet granules or regulating platelet surface integrin activation. tm1Tyj /J colony) [16] were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and housed with free access to food and water.
Materials and methods

Mice
Injection of Tpo to stimulate in vivo megakaryopoiesis p53 À/À mice and age-matched p53 þ/þ littermates less than 3 months of age were injected once subcutaneously with 1.2 mg recombinant murine (rm) Tpo (Peprotech, Rocky Hill, NJ, USA) diluted in saline or saline as control [20, 21] . On days 2 and 5 after Tpo treatment, the mice were bled retro-orbitally and sacrificed. Platelets were enumerated using the Unopette reservoirs (Becton-Dickinson, Franklin Lakes, NJ, USA) and a hemacytometer (Hausser, Horsham, PA, USA).
Injection of anti-CD41 antibody to induce thrombocytopenia p53 À/À mice and age-matched p53 þ/þ littermates less than 4 months of age were injected once intraperitoneally with 0.5 mg rat anti-mouse CD41 (clone: MWReg30; BD-Pharmingen, San Diego, CA, USA) per gram of body weight [22] . The antibody had been dialyzed before injection for 4 hours in 1 L ice-cold phosphate-buffered saline (PBS) to remove traces of sodium azide using the Slide-A-Lyzer mini dialysis units (Pierce, Rockford, IL, USA). Daily blood counts were conducted for 5 days using a Hemavet (Drew Scientific, Waterbury, CT, USA). Some of the mice were sacrificed on day 2 after anti-CD41 injection, while the rest were sacrificed on day 5 in order to harvest BM.
Detection of reticulated platelets by staining with thiazole orange and measurement of CD41 expression on platelets Reticulated platelets were measured as described previously [23] . Briefly, 1 mL EDTA-anticoagulated blood was incubated in a total volume of 60 mL with 10 mg/mL thiazole orange (Sigma-Aldrich, St Louis, MO, USA) and 1 mL anti-CD41-phycoerythrin (clone MWReg30; BD-Pharmingen) for 15 minutes in the dark at room temperature. Samples were then fixed by addition of 1% paraformaldehyde for no more than 30 minutes at room temperature and acquired on a FACSAria. Measurement of CD41 mean fluorescence using flow cytometry was used to estimate aIIbb3 expression on the platelet surface.
Tpo levels in serum Blood was collected from the retro-orbital vein using plain Natelson capillaries and left to clot at room temperature in the absence of anticoagulant. Serum was then collected by high-speed centrifugation. Tpo levels in the serum were measured using the Quantikine mouse Tpo ELISA (R&D Systems, Minneapolis, MN, USA) [22] . Absorbance was read at 450 nm with the correction set to 595 nm using a DTX880 microplate reader (BeckmanCoulter, Brea, CA, USA).
Murine Mk cell culture
Red blood cell-depleted BM cells were processed as described in our previous study [7] and cultured in Iscove's modified Dulbecco's medium/10% fetal bovine serum/1% penstrep media containing 50 ng/mL rmTpo [24] . Culture flasks were maintained in a fully humidified incubator at 37 C and 5% CO 2 .
Detection of ploidy, DNA synthesis and apoptosis in Mk cells
To detect ploidy among Mk cells, red blood cell-depleted BM cells or cultured Mk cells were stained with anti-CD41-fluorescein isothiocyanate (FITC; BD Pharmingen), fixed with 0.5% paraformaldehyde in PBS, permeabilized with 70% methanol, treated with 10 mg/mL RNAse and counterstained with propidium iodide [7, 25] . For DNA synthesis, p53 þ/þ and p53
Mk cell cultures were incubated for 12 hours with 10 mM bromo-deoxy-uridine (BD Pharmingen) at 37 C, then stained with anti-CD41-FITC, fixed and permeabilized per the manufacturer's protocol, treated with 10 mg/mL RNAse and stained with PI [7] . For detection of Mk apoptosis, Hoechst 33342 was directly added at 0.01 mM into the Mk cell cultures and incubated for 2 hours at 37 C/5% CO 2 [26] . At the end of the incubation, Mk cells were washed with phosphate-buffered saline, stained with anti-CD41-FITC for 30 minutes at 4 C, washed again with PBS, resuspended in 1Â Annexin binding buffer (BD Pharmingen), stained with Annexin V-PE (BD-Pharmingen) and acquired.
Mouse tail-bleeding assays Mice were anesthetized by isoflurane inhalation, tails were prewarmed at 37 C for 5 minutes, 3-mm of the distal end was cut off using a scalpel, and the tail was immersed into fresh saline prewarmed at 37 C. Primary bleeding time is defined as the time until bleeding cessation for a minimum of 10 seconds. If bleeding resumed, the duration of the primary and subsequent bleeds were added up and reported as the total bleeding time. If the primary or total bleeding time exceeded 10 minutes, the assay was stopped and the tail was taken out of the saline and pressure was applied to stop the bleeding in order to avoid losing too much blood [27] .
Flow cytometric and microscopical assessment of platelet stimulation with agonists Heparinized blood was collected from the retro-orbital veins and platelet-rich plasma was isolated by low-speed centrifugation. Platelet-rich plasma was passed through a Sepharose column as described previously [28] , gel-filtered platelets were isolated and calcium was added to a final concentration of 1 mM. For flow cytometric assays, Alexa-Fluor-488-conjugated fibrinogen (Molecular Probes, Eugene, OR, USA) or FITC-conjugated anti-P-selectin (BD Pharmingen) were added at 12.5 mg/mL or 1:100 dilution, respectively, together with a range of concentrations of AYPGKF (Kimmel Cancer Center of the Thomas Jefferson University, Philadelphia, PA, USA), a PAR-4 agonist peptide. The platelets were stimulated for 10 minutes at 37 C, then fixed for 10 minutes with 2% paraformaldehyde at room temperature. For microscopy, gel-filtered platelets were stimulated for 5, 15, or 30 minutes at 37 C with 50 mM AYPGKF or 10 mM phorbol 12-myristate 13-acetate (PMA) on glass slides precoated with 100 mg/mL human fibrinogen (Enzyme Research Laboratories, South Bend, IN, USA). Platelets were fixed and permeabilized as described [28] , stained with Alexa Fluor-568-phalloidin and mounted. Slides were examined using an LSM 5 Live High Speed Confocal microscope (Zeiss, Oberkochen, Germany) equipped with a 100Â oil objective.
Microarray analysis of p53 knock-down (KD) relative to control CHRF cells CHRF is a wild-type p53
blastic cell line, which responds to PMA and undergoes polyploidization coupled with marked apoptosis and extension of proplatelet-like cytoplasmic protrusions. P53-KD and control human megakaryoblastic CHRF cells were cultured in Iscove's modified Dulbecco's medium/10% fetal bovine serum and stimulated with 10 ng/mL PMA to induce terminal Mk differentiation, as described previously [7, 9, 29] . Cell samples taken from two independent biological replicate sets of p53-KD and control CHRF cell cultures either unstimulated (day 0) or on days 1, 3, 5, and 7 following stimulation with PMA were flash-frozen in liquid nitrogen to be used later for microarray analysis. Experimental methods for CHRF cell culture, RNA isolation, labeling, and hybridization for the microarray analysis in CHRF cells and data normalization have been described [9, 30] . All data have been deposited in Gene Expression Omnibus as mandated by the Minimum Information about Microarray Experiment (MIAME) standards and have been assigned series record GSE30984. A list of platelet activation-related genes was curated based on the literature [6, 9, [31] [32] [33] . Differentially expressed genes were identified using statistical analysis of microarrays as implemented in MeV with a false discovery rate !0.05 [34] . Validation of microarray findings was done with real-time polymerase chain reaction, as described in our previous work [7] using Taqman probes for ITGA2B (Hs01116228_m1), SELP (Hs00356351_m1), and MYH9 (Hs00159522_m1) from Applied Biosystems (Foster City, CA, USA). Data were normalized against housekeeping gene GUSB (Hs99999908_m1).
Statistical analysis
Unless otherwise noted, all statistical comparisons were conducted using an unpaired two-tailed Student's t-test.
Results
Increased polyploidization and cell size observed in cultured p53 À/À Mk cells are caused by greater DNA synthesis and diminished apoptosis during megakaryopoiesis in the absence of p53 We have previously shown that knock-down of p53 in human megakaryoblastic CHRF cells led to increased Mk polyploidization in part due to greater DNA synthesis upon induction of Mk differentiation [7] . Additionally, we have shown that p53 À/À culture-derived mouse Mk cells reach higher ploidy classes than p53 þ/þ Mk cells [7] . Here, we aimed to better characterize this ex vivo-observed hyperploid murine p53 À/À Mk phenotype. BM cells harvested from p53 À/À mice and age-matched p53 þ/þ littermates were cultured ex vivo in the presence of 50 ng/mL Tpo for 6 days to induce Mk differentiation. Cell size analysis of p53 þ/þ and p53 À/À cultured CD41 þ cells was performed using the forward scatter area signal [35] . On day 6 of culture, the mean 6 standard error of mean (SEM) forward scatter signal for p53 þ/þ and p53 À/À CD41 þ cells was 121 6 4 and 151 6 9 (n 5 7, p 5 0.01), indicating that cell size was significantly increased in the highly polyploid p53 À/À Mk cells. As we have previously observed [7] , Mk cells derived from p53 À/À BM progenitor cells always reached higher ploidy classes and exhibited higher percentage of highly polyploid cells. By day 6 of culture, there was a 1.7-fold increase in total CD41
þ Mk cells for p53 À/À Mk cells (n 5 7, p ! 0.02; Fig. 1A ) and substantially increased polyploidy: 26.1% 6 3.6% of p53 À/À vs 8.2% 6 0.9% of p53 þ/þ Mk cells reached ploidy classes $64N (n 5 7, p 5 0.0004; Fig. 1B) .
Increased polyploidization observed in culture was partially due to 30% enhanced DNA synthesis among p53 À/À Mk cells on day 4 of culture (n 5 3-4; p ! 0.03; Fig. 1C, D) . Moreover, there was a tendency for increased polyploidization in $32N ploidy classes among actively cycling Mk cells (bromo-deoxy-uridine þ ) in p53 À/À Mk cells on day 4 (n 5 3-4; Fig. 1E, F) . This finding indicated that increased DNA synthesis largely occurred in the highly polyploid ($32 N) population of p53 À/À Mk cells. Increased polyploidization in ex vivo-cultured p53
Mk cells can also be ascribed to diminished apoptosis in the absence of p53. Indeed, apoptosis, measured among nucleated CD41 þ cells by assessing binding of Annexin V, was increased by an average of 31% in p53 þ/þ Mk cells on day 4 of culture with Tpo ( Fig. 2A, B) .
Tpo administration leads to increased in vivo Mk polyploidization in p53
À/À mice Mk cells in the BM were measured as the percent of nucleated CD41 þ cells. The numbers of BM-resident Mk cells were similar in p53 þ/þ and p53 À/À mice (0.21% 6 0.03% for both genotypes, n 5 7), while among p53 À/À mice have normal serum Tpo levels and platelet synthesis and only slightly lower platelet counts compared to their p53 þ/þ counterparts (Table 1) .
In order to examine the effect of p53 loss on in vivo Mk polyploidization and platelet formation under conditions of increased platelet production as a result of induced thrombocytopenia, we administered 0.5 mg anti-CD41 antibody per gram of body weight to p53 À/À mice and p53 þ/þ agematched littermates. Five days after anti-CD41 treatment, platelet counts were higher than their normal levels in p53 À/À and p53 þ/þ mice (n 5 5; Supplementary Figure E1A ; online only, available at www.exphem.org). Even though there was a tendency for increased platelet synthesis in p53
À/À mice, we did not observe significant differences in the rate of platelet recovery between p53 À/À and p53 þ/þ mice or in Mk content and polyploidization in the BM (Supplementary Figure E1; online only, available at www.exphem.org).
To determine whether Tpo induces increased polyploidization in vivo, as we have seen in cultured p53 À/À Mk cells, we administered 1.2 mg Tpo to p53 À/À mice and p53 þ/þ age-matched littermates. Five days after Tpo treatment, in agreement with the ex vivo data shown in Figure 1 , we found higher Mk ploidy in the BM of p53 À/À mice: 37.7% 6 5.4% p53 À/À Mks reached ploidy of $16 N compared to 20.7% 6 3.2% p53 þ/þ Mks (p ! 0.06, n 5 3-4; Fig. 3A, B) . In addition, 5 days after Tpo treatment, we found a tendency for increased BM content of p53
þ/þ Mks relative to 0.23% 6 0.03% of p53 À/À Mks (n 5 3-4; Fig. 3C ). Even though steady-state platelet counts were similar (Fig. 3D) , the increase in p53 À/À Mk polyploidization was accompanied by a tendency for modestly increased platelet formation (n 5 3-4; Fig. 3E ).
p53
À/À mice have longer bleeding times Because we have shown a role for p53 in Mk development, we wondered whether p53 expression might affect hemostatic function. Indeed, wild-type platelets express p53 despite lacking a nucleus (Supplementary Figure E2; online only, available at www.exphem.org). To determine whether p53 influences hemostasis, tail-bleeding times were assessed in p53 À/À and p53 þ/þ mice [27, 36] . Bleeding data collected for mice younger than 10 weeks of age indicated hemostatic deficiencies in p53 À/À mice. Primary bleeding times were prolonged in p53 À/À mice (mean 6 SEM: 5.4 6 1.2 minutes) compared to p53 þ/þ mice (mean 6 SEM: 2.1 6 0.5 minutes) (n 5 10-11; p ! 0.02) and the duration of the primary bleed for 3 of 10 p53
À/À mice exceeded 10 minutes (Fig. 4A) . Total bleeding times were also prolonged in p53 À/À mice (mean 6 SEM: 8.8 6 0.9 minutes) compared to p53 þ/þ mice (mean 6 SEM: 5.3 6 1.0 minutes) (n 5 10-11; p ! 0.02; Fig. 4B ).
Indeed, 8 of 10 p53
À/À mouse tail bleeds exceeded the 10-minute duration of the assay relative to 2 of 10 p53 þ/þ mouse tail bleeds.
p53
À/À platelets are less sensitive to a PAR-4 agonistinduced fibrinogen binding than p53 þ/þ platelets We next examined fibrinogen binding of isolated platelets from p53 À/À mice in response to AYPGKF, a specific agonist for the thrombin receptor PAR4 [37] . The affinity of the platelet integrin aIIbb3 for fibrinogen is low in unstimulated platelets. Thrombin stimulation elicits inside-out signaling by the integrin, leading to a high affinity of aIIbb3 for circulating fibrinogen. We found that platelets from p53 À/À mice are less sensitive to PAR4 agoniststimulated fibrinogen binding than p53 þ/þ platelets (Fig. 5) . In particular, responses to 65 to 80 mM AYPGKF were significantly higher in p53 þ/þ relative to p53 À/À platelets. The decreased sensitivity of p53 À/À platelets to agonist-induced fibrinogen binding is not due to decreased expression of aIIbb3, since this is equivalent in p53 þ/þ and p53 À/À mouse platelets, as determined by flow cytometric measurement of aIIb expression [38] (p53 þ/þ : 6500 6 300 vs p53 À/À : 6900 6 300, n 5 9). Furthermore, in a static adhesion assay of AYPGKF-or PMA-stimulated platelets, p53 þ/þ and p53 À/À platelet activation responses were similar judging by the extension of lamellipodia, and spreading of the flattened platelets on the fibrinogencoated glass surface (Supplementary Figure E3; online only, available at www.exphem.org). These findings suggest that there is no defect in outside-in signaling in p53 À/À platelets, but that it is likely either a specific defect in inside-out signaling or granule secretion in p53 À/À platelets that contributes to the hemostatic defect in these mice.
À/À platelets are less sensitive to a PAR-4 agonistinduced secretion of P selectin (CD62P) on their surface than p53 þ/þ platelets Because some defects in sensitivity to agonist-induced fibrinogen binding are attributable to secretion defects, we examined the ability of isolated p53 À/À platelets to undergo degranulation and expose P-selectin, the a granule component, on their surface following exposure to the PAR4 agonist AYPGKF [37] . p53 À/À platelets are less sensitive than p53 þ/þ platelets to PAR-4-stimulated P-selectin exposure (Fig. 6) . This finding suggests a defect in PAR4-agonist-dependent a granule secretion in platelets lacking p53.
Genes coding for platelet integrin, cytoskeletal, and a granule components are differentially regulated in p53-KD vs control CHRF cells In order to shed more light on platelet components that could be affected directly or indirectly by p53 and participate in the hemostatic response, we carried out a microarray-based transcriptional analysis comparing p53-KD and control megakaryoblastic CHRF cells induced by PMA to undergo terminal Mk differentiation [7] . The decision to use a human cell line rather than primary murine cells was based on several considerations. First, because we ultimately care to understand megakaryopoiesis and thrombopoiesis in humans, we argued that because the impact of p53 on megakaryopoiesis has been observed in both human and mouse Mk cells [7] , any systemic effects of p53 on platelet-related genes would likely be preserved between the human and murine Mk cells. Second, there is a greater database of microarray data amassed for human megakaryopoiesis [6, 8, 9, 25] . Thus, given the extensive validation of the CHRF cell line as a sound model of human megakaryopoiesis [9] , we chose to compare the transcriptional profile of p53-KD CHRF cells to that of control CHRF cells [7] . A list of platelet-related genes was curated based on published literature data [6, 9, [31] [32] [33] and differentially expressed genes were identified using statistical analysis of microarrays [34] . Thus, a number of genes coding for proteins important in hemostasis, but not known to carry p53-responsive sequences in their promoter regions, were differentially regulated (Fig. 7) . Two genes coding for G-protein-coupled receptors (SUCNR1, P2RY1) and CCL5, coding for RANTES (regulated on activation, normal T expressed and secreted), a component of platelet a granules, were strongly upregulated in p53-KD CHRF cells. Genes that were downregulated in p53-KD CHRF cells code for platelet surface integrins [ITGB3 (CD61), GP5 (CD42d), ITGA2B (CD41)] and components of platelet a granules (SELP [P-selectin], SPARC, LTBP, PPBP). Fibrinogen, von Willebrand factor, and collagen receptors on the platelet surface are complexes with roles in mediating platelet adhesion and aggregation. The fibrinogen receptor, composed of integrins CD41 and CD61, assumes the activated conformation upon agonist stimulation, allowing ligand binding (e.g., fibrinogen, von Willebrand factor, fibronectin, and vitronectin) [39] .
In addition, components of the platelet or Mk proplatelet cytoskeleton that are essential in platelet functions (MYH9, GSN, CTNNB1, ACTA2, VCL, TUBB1, CTTN, PSTPIP2) were found to be downregulated in p53-KD CHRF cells ( Fig. 7) . Also found among the downregulated genes were two p53 targets: a gene coding for a Gi-family subunit (GNAI1) and a gene coding for a protein kinase C isoform, essential in dense granule secretion (PRKCA) [40] . Microarray findings for ITGA2B, SELP, and MYH9 were validated using real-time polymerase chain reaction (Supplementary Figure E4 ; online only, available at www.exphem.org). Our microarray findings suggest the possibility that genes coding for proteins important in platelet activation are indirectly regulated by p53. The differential regulation of these important platelet components in p53-KD compared to control CHRF cells is in line with the finding of altered platelet functionality leading to hemostasis defects in p53 À/À mice. Future work will examine the possibility of regulation of these platelet components by p53 in megakaryocytes and platelets.
Discussion
High expression of the p53 protein in both diploid and polyploid primary human Mk cells has been reported previously [41] , but the implications have remained unclear. Indeed, the process of polyploidization during terminal Mk differentiation could activate p53, potentially as a result of cellular stress and DNA damage, when the cells fail to complete cytokinesis and revert to G 1 and S phases.
Prompted by our preliminary findings on the activation of the p53 transcriptional network over the course of Mk differentiation in culture [6, [8] [9] [10] and the finding that p53 knockdown leads to enhanced polyploidization during Mk differentiation ex vivo [7] , we set out to characterize the effect of p53 loss on megakaryopoiesis and platelet production, and hemostasis in vivo.
In vivo vs in vitro megakaryopoiesis in the absence of p53 We were unable to find differences in Mk content in the BM or spleen, BM Mk ploidy or platelet counts between p53 þ/þ and p53 À/À mice (Table 1 and data not shown). By contrast, when p53
À/À BM cells were cultured with Tpo, they reached substantially higher levels of Mk polyploidy than p53 þ/þ Mk cells (Fig. 1) , which was due in part to enhanced DNA synthesis, especially in the polyploid compartment and in part to diminished apoptosis ( Figs. 1  and 2 ). Indeed, in several cases, p53
À/À Mk cells were able to reach ploidy classes of up to 256 N by day 6 of culture with Tpo ( Fig. 1) . A role for p53 as a regulator of DNA synthesis in Mk cells is consistent with an earlier finding that knock-down of p53 could increase Mk colony formation in cultures of peripheral blood mononuclear cells [42] . In an attempt to emulate in vivo the hyperploid p53
Mk phenotype observed in vitro, we supplied Tpo to induce Mk polyploidization and thrombocytosis [21, 43] . Five days following treatment, we observed increased p53 À/À Mk polyploidy compared to p53 þ/þ Mk cells; however, platelet numbers were similar in p53 þ/þ and p53 À/À mice (Fig. 3) . We next evaluated the ability of p53 À/À Mk cells to restore normal platelet levels in vivo following induced thrombocytopenia [44] . To our surprise, the kinetics of platelet production and the extent of Mk polyploidization were almost identical in p53 þ/þ and p53 À/À mice (Supplementary Figure E1; online only, available at www. exphem.org). However, when BM cells from p53 À/À mice treated with either Tpo or anti-CD41 were put in culture, they always reached significantly higher ploidy classes than Mk cells derived from p53 þ/þ BM cells (data not shown).
The results here evoke the effects on Mk differentiation of p21, a p53-dependent cyclin-dependent kinase inhibitor, and survivin, a chromosome passenger protein that functions in the spindle assembly checkpoint and cytokinesis. p21 À/À [41] and survivin-deficient [45] or -over-expressing [46] mice have normal steady-state Mk development and platelet levels. Nevertheless, loss of p21 has been linked to enhanced polyploidization in vitro [47] . Furthermore, overexpression of survivin in vitro has been shown to arrest polyploidization [48] , while its loss in vitro has been shown to promote polyploidization [45] . Considering that earlier studies in non-Mk cells have highlighted the necessity of deletion of both p53 and survivin for the spontaneous induction of polyploidization [49, 50] , it is tempting to speculate that loss of both cell cycle regulators would effect a severely hyperploid [51] . Another possibility is that c-Myc, an oncogene whose overexpression is by itself sufficient to induce polyploidization in cancer cells in the absence of p53 [52] , is repressed by p53 [53] . Notably, c-Myc À/À mice have pronounced Mk and platelets defects, such as increased BM Mk content, decreased Mk polyploidization, and significantly increased thrombocytosis presumably due to the fourfold increase of Mk progenitor cells in c-Myc À/À mice [54] . It is also possible that age-related [2] or sex-related [19] differences or systemic compensatory mechanisms, such as splenic sequestration of platelets [55] , activation of p63 and p73 members of the p53 family in the absence of p53 [56] , or even polyploid Mk cell progression into cytokinesis [57] could mask the effect of p53, p21, or other modulators on individual steps of megakaryopoiesis in vivo. Conceivably, use of Mk/plateletspecific p53 knockout mice might alleviate systemic compensation.
Impact of p53 loss on platelet function and hemostasis A very recent publication has provided an indirect link between impaired hemostasis and low levels of p53 in the context of Mk cells: it was demonstrated that mice lacking the PER2 gene exhibit increased bleeding times, delayed clot retraction, and attenuated aggregation and secretion, while their Mk cells evade apoptosis and have lower p53 levels [58] . In our study, platelets from p53 À/À mice appear to be less efficient in maintaining hemostatic plugs, as indicated by prolonged bleeding upon standardized injury (Fig. 4) . Moreover, p53 À/À platelets are less sensitive to agonist-mediated activation in binding fibrinogen (Fig. 5) or secreting P-selectin from a granules to their surface (Fig. 6) . Because spreading on fibrinogen-covered surfaces (Supplementary Figure E3; online only, available at www. exphem.org) and aIIbb3 expression were normal in p53 À/À platelets, our data suggest a specific defect in inside-out signaling or degranulation. To our knowledge, this is the first study indicating a direct link between hemostatic deficiencies and the absence of p53. Our findings may, in part, be explained by p53-mediated direct or indirect regulation in the context of terminal Mk differentiation of a set of genes coding for platelet receptors and components of the platelet cytoskeleton and a granules. For instance, ACTA2, a p53 target coding for actin A2, and MYH9, coding for myosin IIA, are both downregulated in p53-KD CHRF cells undergoing Mk differentiation. Actin associates with myosin to form actomyosin fibers participating in platelet contraction, which has been speculated to be responsible not only for platelet shape change but also for release of the platelet granule contents [59] . Moreover, p53-mediated downregulation of other actin-related cytoskeletal components, such as GSN or CTTN, coding for gelsolin and cortactin, respectively, may be in part responsible for defects in platelet activation. Indeed, gelsolin participates in actin remodeling [60] and its loss leads to attenuated shape change of activated platelets and prolonged tail-bleeding times [61] , while cortactin has roles in actin remodeling during platelet activation [62] . While p53 À/À platelet shape change and actin polymerization during fibrinogen spreading appeared normal, we cannot exclude the possibility that the downregulation of actin and myosin-related components in p53-KD CHRF cells is associated with increased Mk polyploidization as CHRF cells grow adherent; actomyosin inhibition was recently linked to increased Mk polyploidization and proplatelet extension [63] . Additionally, low levels of Mk/platelet-specific b1 tubulin in p53-KD CHRF cells may suggest defects in Mk proplatelet formation resulting in attenuated packaging of granules and other organelles into the nascent platelets [64, 65] .
In summary, we have demonstrated that p53 À/À platelets exhibit an impaired response to agonist-induced activation of the fibrinogen receptor and secretion of P-selectin on their surface. This finding may explain the longer tail bleeding times observed in p53 À/À mice. Additional studies are required to determine if p53 loss affects the platelet structure and the composition of the a granules and to address the possibility of p53 affecting platelet function through nontranscriptional pathways. 
